Seul-A Seo

Seul-A Seo

Auto-generated profile, based on publicly available information

Seul-A Seo

Cell Green Biolab Co., Ltd 06164 Seoul Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2021 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
MSmoon young song
moon young song
DLDa-Young Lee
Da-Young Lee
SPSang-Yong Park
Sang-Yong Park
SSSeul-A Seo
Seul-A Seo
JHJeong-Seung Hwang
Jeong-Seung Hwang
Eun-Hee KimEun-Hee Kim
Eun-Hee Kim
Moon-Young Song, Da-Young Lee, Sang-Yong Park, Seul-A Seo, Jeong‑Seung Hwang, Soo-Hyeon Heo, Eun-Hee Kim. J Cancer Prev 2021;26:289-97. https://doi.org/10.15430/JCP.2021.26.4.289

30 June 2025 in Food Science and Preservation
Verified
Journal Article
Open access
PDF file
SHSoo-Hyeon Heo
Soo-Hyeon Heo
SSSeul A Seo
Seul A Seo
KYKg Dinesh Yadav
Kg Dinesh Yadav
VBVadiraj Gururaj Bharadwaj
Vadiraj Gururaj Bharadwaj
SASrilakshmi Aluri
Srilakshmi Aluri
HCHyun-Dong Cho
Hyun-Dong Cho
Lipid metabolism disorders such as hypercholesterolemia, hyperlipidemia, and hyperglycemia collectively characterize dyslipidemia, a condition marked by an imbalance in blood lipid levels and impaired lipid homeostasis. Policosanol, a mixture of long-chain alcohols derived from sugarcane, has been reported to improve lipid metabolism, but its cellular mechanisms remain underexplored. This study investigated the effects of policosanol (Reduchole22®) extracted using ethanol on lipid metabolism in HepG2 hepatocytes and Caco-2 enterocytes. The data were compared with atorvastatin, a widely used hyperlipidemia drug. Compared to the control group, 250-500 μg/mL of policosanol significantly reduced intracellular cholesterol and lipid accumulation via downregulating SREBP, ACAT, and APOB and upregulating LDL-receptor, ABCA1, and APOA1 in HepG2 cells. In addition, treatment of policosanol (250-500 μg/mL) markedly inhibited HMG-CoA reductase and ACAT2 expression, leading to decreased cholesterol and total lipid accumulation in Caco-2 cells. Moreover, policosanol suppressed H2O2-induced LDL oxidation in HepG2 cells, resulting in potential activity in preventing dyslipidemia. These findings suggest that policosanol (Reduchole22®) mediates cholesterol metabolism through mechanisms similar to atorvastatin. Moreover, it could be applied as a functional food ingredient for hyperlipidemia management in endogenous and exogenous cholesterol metabolism, providing a beneficial alternative in the food industry.

30 October 2025 in Food Science and Preservation
Verified
Journal Article
Open access
PDF file
SSSeul A Seo
Seul A Seo
SHSoo-Hyeon Heo
Soo-Hyeon Heo
KYKallu Golla Dinesh Yadav
Kallu Golla Dinesh Yadav
SPSang Hyun Park
Sang Hyun Park
HCHyun-Dong Cho
Hyun-Dong Cho
SHSeong Min Hong
Seong Min Hong
Policosanol, a mixture of long-chain aliphatic alcohols derived from sugarcane, is a promising nutraceutical for lowering blood cholesterol levels. Previous studies have reported cholesterol-lowering mechanisms, such as adenosine monophosphate-activated protein kinase (AMPK) activation, HMG-CoA reductase (HMGCR) inhibition, LDL receptor upregulation, and enhanced bile acid excretion. However, the underlying mechanisms related to additional aspects of cholesterol biosynthesis and lipid metabolism have not been fully elucidated. In this study, we evaluated the cholesterol-lowering effects of policosanol (Reduchole22®), a policosanol purified from sugarcane ethanol extract, in a high-fat diet (HFD)-induced mouse model. Our in vivo results showed that policosanol significantly reduced the atherogenic index in plasma and inhibited key enzymes involved in cholesterol synthesis, including HMGCR and acetyl-CoA acetyltransferase 1 (ACAT1), in both hepatic and arterial tissues. Our results confirmed previously reported mechanisms, including significant reductions in the atherogenic index, HMGCR and acetyl-CoA acetyltransferase 1 (ACAT1) inhibition, increased ATP-binding cassette transporter G5 (ABCG5) expression, and enhanced cholesterol 7α-hydroxylase (CYP7A1) activity, thus promoting cholesterol excretion. Notably, our study uniquely elucidates policosanol’s modulation of cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT), and paraoxonase 1 (PON1), providing deeper insights into HDL function, antioxidative defense mechanisms, and comprehensive lipid metabolism regulation. Our findings highlight policosanol as a distinct functional food ingredient for managing hypercholesterolemia and cardiovascular disease.

31 October 2025 in Food Science and Preservation
Verified
Journal Article
Open access
PDF file
SSSeul A Seo
Seul A Seo
SHSoo-Hyeon Heo
Soo-Hyeon Heo
KYKallu Golla Dinesh Yadav
Kallu Golla Dinesh Yadav
SPSang Hyun Park
Sang Hyun Park
HCHyun-Dong Cho
Hyun-Dong Cho
SHSeong Min Hong
Seong Min Hong
Policosanol, a mixture of long-chain aliphatic alcohols derived from sugarcane, is a promising nutraceutical for lowering blood cholesterol levels. Previous studies have reported cholesterol-lowering mechanisms, such as adenosine monophosphate-activated protein kinase (AMPK) activation, HMG-CoA reductase (HMGCR) inhibition, LDL receptor upregulation, and enhanced bile acid excretion. However, the underlying mechanisms related to additional aspects of cholesterol biosynthesis and lipid metabolism have not been fully elucidated. In this study, we evaluated the cholesterol-lowering effects of policosanol (Reduchole22®), a policosanol purified from sugarcane ethanol extract, in a high-fat diet (HFD)-induced mouse model. Our in vivo results showed that policosanol significantly reduced the atherogenic index in plasma and inhibited key enzymes involved in cholesterol synthesis, including HMGCR and acetyl-CoA acetyltransferase 1 (ACAT1), in both hepatic and arterial tissues. Our results confirmed previously reported mechanisms, including significant reductions in the atherogenic index, HMGCR and acetyl-CoA acetyltransferase 1 (ACAT1) inhibition, increased ATP-binding cassette transporter G5 (ABCG5) expression, and enhanced cholesterol 7α-hydroxylase (CYP7A1) activity, thus promoting cholesterol excretion. Notably, our study uniquely elucidates policosanol’s modulation of cholesteryl ester transfer protein (CETP), lecithin-cholesterol acyltransferase (LCAT), and paraoxonase 1 (PON1), providing deeper insights into HDL function, antioxidative defense mechanisms, and comprehensive lipid metabolism regulation. Our findings highlight policosanol as a distinct functional food ingredient for managing hypercholesterolemia and cardiovascular disease.